Lataa...
Single-cell RNA sequencing of Tocilizumab-treated peripheral blood mononuclear cells as an in vitro model of inflammation
COVID-19 has posed a significant threat to global health. Early data has revealed that IL-6, a key regulatory cytokine, plays an important role in the cytokine storm of COVID-19. Multiple trials are therefore looking at the effects of Tocilizumab, an IL-6 receptor antibody that inhibits IL-6 activit...
Tallennettuna:
| Julkaisussa: | bioRxiv |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Cold Spring Harbor Laboratory
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7491509/ https://ncbi.nlm.nih.gov/pubmed/32935096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.09.11.281782 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|